the journal of Pharmacy Technology the journal of Pharmacy Technology
Abstracts of Back Issues
Home
Home
Back Issues
Author Information
PharmaCE
Acknowledgments
About the journal
Order Form
Customer Service
Advertising Information
Contact Information


SELECTIVE SEROTONIN-REUPTAKE INHIBITORS IN PREMENSTRUAL DYSPHORIC DISORDER
Irma G Barcelona and Laurie S Mauro

To request full article click here.

OBJECTIVE: To briefly review the symptoms of premenstrual syndrome (PMS), late luteal-phase dysphoric disorder (LLPDD), and premenstrual dysphoric disorder (PMDD); summarize the physiologic relationship between serotonin and these disorders; and review the available clinical information on the role of selective serotonin-reuptake inhibitors (SSRIs) in the treatment of LLPDD/PMDD.

DATA SOURCES: A MEDLINE search for English-language journal articles published between 1966 and August 2000 was performed, with the following keywords: serotonin reuptake inhibitors, fluoxetine, sertraline, or paroxetine matched with premenstrual syndrome, late luteal-phase dysphoric disorder, or premenstrual dysphoric disorder.

DATA SELECTION AND EXTRACTION: All English-language clinical studies of SSRIs for LLPDD/PMDD were included. Study design, population, methods, clinical outcomes, and adverse effects were evaluated.

DATA ANALYSIS: Continuous therapy with SSRIs, particularly fluoxetine and sertraline, is beneficial in the pharmacotherapy of LLPDD/PMDD. Response rates vary, but are generally near 65% for global clinical outcomes. Both behavioral and physical symptoms are improved. Studies as long as 18 months have demonstrated continued benefit with SSRI therapy. Recent literature suggests that intermittent therapy with these agents, only during the luteal phase, may provide benefits similar to those achieved with continuous therapy in selected patients.

CONCLUSIONS: The SSRIs, particularly fluoxetine and sertraline, are useful in the pharmacotherapy of LLPDD/PMDD.

J Pharm Technol 2001;17:131-9.

ACPE Universal Program Number: 407-000-01-052-H01

To order the complete CE article click here.

To request full article click here.


Harvey Whitney Books


Harvey Whitney Books

 
 

the journal of Pharmacy Technology
is published by HARVEY WHITNEY BOOKS COMPANY
8044 Montgomery Road, Suite 415, Cincinnati, OH 45236-2919
P.O. Box 42696, Cincinnati, OH 45242-0696 USA
Tel. 513/793-3555, FAX 513/793-3600
Office Hours: 9-5 E.S.T.
Contact Information
All Rights Reserved. Copyright © 1998-